Laura Mondano
Keine laufenden Positionen mehr
Profil
Laura Mondano worked as a Director of Global Regulatory Affairs at Genzyme Corp.
and as a Manager of Regulatory Affairs at both Boston Scientific Corp.
and Anika Therapeutics, Inc. She then served as the Vice President of Regulatory and Quality at Histogenics Corp.
from 2012 to 2016, and as the Vice President of Regulatory Affairs at Harvard Apparatus Regenerative Technology, Inc. Ms. Mondano received her undergraduate degree from the University of New Hampshire.
Ehemalige bekannte Positionen von Laura Mondano
| Unternehmen | Position | Ende |
|---|---|---|
| OCUGEN, INC. | General Counsel | 01.02.2016 |
| ANIKA THERAPEUTICS, INC. | General Counsel | - |
| HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | General Counsel | - |
| BOSTON SCIENTIFIC CORPORATION | General Counsel | - |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | General Counsel | - |
Ausbildung von Laura Mondano
| University of New Hampshire | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Health Technology |
| ANIKA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Histogenics Corp.
 Histogenics Corp. BiotechnologyHealth Technology Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
